ASMS 2024

Hilton Anaheim - California Ballroom

Hear from leaders in the field about how discovering & validating insights at unprecedented scale has never been easier than before, with new technology revealing biological insights into disease mechanisms and clinical research outcomes. Learn about the latest advances in mass spectrometry for proteomics, metabolomics, and translational research.

Speakers:
Karen Nelson, Ph.D., Chief Scientific Officer, Thermo Fisher Scientific
Iain Mylchreest, Ph.D., Vice President, Research and Development AIG, Thermo Fisher Scientific
Michael MacCoss, Ph.D., Professor of Genome Sciences, University of Washington
Jennifer Van Eyk, Ph.D., Director of Advanced Clinical Biosystems Institute, Cedars-Sinai Medical Center
Jeffrey Whiteaker, Ph.D., Director of Proteomics, Fred Hutchinson Cancer Research Center
Bruce Wilcox, Ph.D., Chief Technology Officer at PrognomiQ
Crystal Pace, Ph.D., Senior Research Scientist, Metabolon
Gary Patti, Ph.D., Professor of Chemistry, Washington University in St. Louis
Matthias Mann, Ph.D., Professor of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry

Registration closed

Proteomics breakout: Peptides, Proteins, PTMs, and Proteoforms

9:40 a.m. - 12 p.m. PDT | Hilton Anaheim - California Ballroom C & D

Hear from experts on diverse proteomic applications ranging from single cell proteomics, PTMs, immunopeptidomics using new approaches for label free quantitation and multiplexing approaches.

Speakers:
Steven Gygi, Ph.D., Professor of Cell Biology, Harvard Medical School
Karl Mechtler, Ph.D., Head Proteomics Tech Hub, Research Institute of Molecular Pathology
Lisa Jones, Ph.D., Professor of Chemistry and Biochemistry, University of California, San Diego
Pierre Thibault, Ph.D., Professor of Chemistry,  Université de Montréal
Brian Searle, Ph.D., Assistant Professor of Chemistry and Biochemistry, Ohio State University

Registration closed

Metabolomics breakout: Metabolites, Lipids, and MultiOmics methods

9:40 a.m. - 12 p.m. PDT | Hilton Anaheim - Pacific Ballroom A & B

From metabolomics to lipidomics hear about the most recent advances for comprehensive small molecule characterization and quantitation using SQUAD, untargeted discovery, targeted validation and imaging methods.

Speakers:
Crystal Pace, Ph.D., Senior Research Scientist, Metabolon
Philip Lorenzi, Ph.D., Director of Metabolomics & Proteomics Cores, MD Anderson Cancer Center
Uri Keshet, Ph.D., Technical Director, Metabolomics Core, University of California, Davis
Bernhard Spengler, Ph.D., Professor of Analytical Chemistry, Justus Liebig University Giessen
Facundo Fernandez, Ph.D., Professor of Chemistry and Biochemistry, Georgia Institute of Technology

Registration closed

BioPharma/Structural Biology breakout: Empowering discovery and development for large and small molecules

9:40 a.m. - 12 p.m. PDT | Hilton Anaheim - California Ballroom A

Hear from end users about applying the state-of-the-art LCMS technologies to accelerate pharmaceutical and biopharmaceutical discovery and development, covering diverse applications of chemoproteomics, comprehensive antibody-drug conjugate characterization, disulfide bond mapping, and cell culture media analysis.

Speakers:
Aman Makaju, Ph.D., Scientist at Amgen
Luca Fornelli, Ph.D., Assistant Professor of Biology, University of Oklahoma
Ben Niu, Ph.D., Principal Scientist at Bristol Myers Squibb
Richard Scheltema, Ph.D., Professor of Structural Proteomics, University of Liverpool
Elsa Gorre, Ph.D., Senior Scientist, Johnson & Johnson

Registration closed

Clinical & EFS breakout: Innovations in clinical and translational research

9:40 a.m. - 12 p.m. PDT | Hilton Anaheim - California Ballroom B

Hear from experts on the latest innovations for diagnostic research studying diseases from Alzheimer’s, Oncology, and Diabetes by measuring protein, lipid, metabolite biomarkers and PFAS using standardized LC-MS workflows for clinical research and environmental safety.

Speakers:
Joel Braunstein, M.D., Chief Executive Officer, C2N Diagnostics
Steve Sweet, Ph.D., Director, Diagnostic Proteomics at AstraZeneca
Jun Qu, Ph.D., Professor of Pharmaceutical Sciences, University at Buffalo
Sangtae Kim, Ph.D., Chief Technology Officer at Bertis Bioscience
Lee Ferguson, Ph.D., Associate Professor of Ecotoxicology and Environmental Health at Duke University

Registration closed